NeuroDM
Accelerating the clinical evaluation of innovative medical devices in neurosurgery and neurosciences
About Us
NeuroDM is a pioneering national network supported by the ANR as part of the France 2030 program. It brings together four major Parisian neurosurgery centers: the Lariboisière Hospital (AP-HP), the Beaujon Hospital (AP-HP), the Necker Hospital, and the Fondation Adolphe de Rothschild Hospital. Coordinated by Professor Sébastien Froelich, the network unites leading clinical and scientific expertise in neurosurgery and neurosciences. In close collaboration with hospital teams, NeuroDM supports MedTech stakeholders, startups, research teams, and academic laboratories in the scientific, clinical, and regulatory evaluation of new medical devices.
NeuroDM is not limited to clinical expertise: the network helps guide projects towards the best experts, the optimal clinical settings, and the most rigorous methodological frameworks. This approach facilitates decision-making, reduces risks, and accelerates the transition from innovation to clinical practice.
Industry Professionals
MedTech Startups
The Evaluation Process
NeuroDM was designed to overcome the usual obstacles in clinical evaluation. Our process guarantees high-level scientific analysis and economic validation in less than one month, thanks to agile governance and streamlined interactions with regulatory authorities (ANSM/CPP).
